CA Patent

CA3047325A1 — Solid pharmaceutical formulations of asimadoline

Assigned to Tioga Pharmaceuticals Inc · Expires 2018-06-28 · 8y expired

What this patent protects

The present invention relates to solid, oral dosage forms of asimadoline comprising lactose monohydrate.

USPTO Abstract

The present invention relates to solid, oral dosage forms of asimadoline comprising lactose monohydrate.

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CA3047325A1
Jurisdiction: CA
Classification: —
Expires: 2018-06-28
Drug substance claim: No
Drug product claim: No
Assignee: Tioga Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.